Navigation Links
Patient Advocate for CancerConnect.com and Acclaimed Writer, Jamie Reno, Delivers Devastating News of Lifesaving Cancer Drug's Discontinuation
Date:8/26/2013

San Diego, CA (PRWEB) August 26, 2013

According to Jamie Reno, an award-winning correspondent for Newsweek, he received a note from GlaxoSmithKline spokesperson, Bernadette King, on August 7th saying that the company would halt the manufacturing and sale of Bexxar on February 14th 2014. Reno immediately then posted the story to his national news blog, The Reno Dispatch. Further citation can also be found at PipelineReview.com in their report published August 6, 2013. The post indicates the many problems with discontinuing the cancer drug and discusses why the drug many have been cancelled in the first place. For Reno, it was a personal blow.

Reno has been in remission for more than thirteen years because of Bexxar, and he has spoken with countless other survivors who wouldn't be here today if it weren't for radio-immunotherapy in the form of Bexxar and its competitor, Zevalin. Although the spokesperson for GSK said they tried to make the drug available to patients through a wide range of options, Reno disputes their claim that their ultimate decision was the correct one. GSK says that they plan to make the cell line that is responsible for the production of Bexxar available for research purposes. Zevalin, which is manufactured by Spectrum Pharmaceuticals, will remain on the market but is also in financial trouble, according to both Reno and Nasdaq.com on August 8, 2013.

Bexxar is a form of radio-immunotherapy that is used to tread non-Hodgkin's lymphoma. It combines radiotherapy with monoclonal therapy to target and kill cancer cells. Bexxar is touted by advocates, patients and some doctors for its longer remissions, much shorter treatment time and fewer side effects than chemotherapy. Although it has been highly successful for many non-Hodgkin's patients, like Mr. Reno, it has not gained wide recognition from the medical community nor patients. In the post, Reno speculates that the reasons for this could include doctor unfamiliarity with the drug, inequitable Medicare reimbursement rates, and fear of the idea of radiation therapy.

For more information and the latest news on Bexxar's discontinuation, radio-immunotherapy, and how this drug saved Reno's life, please check out The Reno Dispatch or contact Reno directly at jreno(at)san(dot)rr(dot)com.

Company/Organization Info: Jamie Reno, a patient advocate for CancerConnect.com and an award-winning correspondent for Newsweek for 20 years, has also written for The Daily Beast, The New York Times, Sports Illustrated, Rolling Stone, People, Men’s Journal, ESPN, Los Angeles Times, TV Guide, Mother Jones, MSNBC, Newsmax, Entertainment Weekly, and USA Today. Reno, who’s won more than 95 writing awards, was the lead reporter on, a Newsweek series on the 9/11 terrorist attacks that earned him and his colleagues the National Magazine Award for General Excellence, the highest award in magazine journalism. Reno is also an acclaimed author, singer-songwriter, advocate for cancer patients, and 16-year cancer survivor.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11054354.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Higher-spending hospitals have fewer deaths for emergency patients
2. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
3. Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
4. Study finds doctors have exaggerated fears when starting patients on insulin
5. Diagnostic Scans Tied to Radiation Risk for Gastro Patients
6. Predictors identified for rehospitalization among post-acute stroke patients
7. Pulse pressure elevation could presage cerebrovascular disease in Alzheimers patients
8. Breast cancer patients suffer treatment-related side effects long after completing care
9. Heart failure patients with diabetes may benefit from higher glucose levels
10. Gastro Woes Often Strike Rheumatoid Arthritis Patients
11. Short Walks May Ease Fatigue in Pancreatic Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Consumers have taken a ... have placed more emphasis on patient outcomes. ... programs in the pharmaceutical industry have evolved beyond ... pharmaceutical companies are focusing on becoming more patient-oriented ... products and services that improve health. ...
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
Breaking Medicine Technology: